Oliver A. Cornely
Researcher Next ID · RN-034064
Researcher · Medicine
TH Köln - University of Applied Sciences
Cologne, Switzerland
- Works count
- 1,056
- Citation count
- 58,189
- H-index
- 113
- i10-index
- 544
Research interests
Publications
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases · 2025 · https://doi.org/10.1016/s1473-3099(24)00749-7
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM
The Lancet Infectious Diseases · 2024 · https://doi.org/10.1016/s1473-3099(23)00731-4
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses
European Respiratory Journal · 2024 · https://doi.org/10.1183/13993003.00061-2024
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
The Lancet Infectious Diseases · 2023 · https://doi.org/10.1016/s1473-3099(22)00872-6
Tackling the emerging threat of antifungal resistance to human health
Nature Reviews Microbiology · 2022 · https://doi.org/10.1038/s41579-022-00720-1
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Kölner Universitäts PublikationsServer (Universität zu Köln) · 2022
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
The Lancet Infectious Diseases · 2021 · https://doi.org/10.1016/s1473-3099(20)30784-2
Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology
The Lancet Infectious Diseases · 2021 · https://doi.org/10.1016/s1473-3099(21)00191-2
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Intensive Care Medicine · 2020 · https://doi.org/10.1007/s00134-020-06091-6
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
The Lancet Infectious Diseases · 2020 · https://doi.org/10.1016/s1473-3099(20)30847-1
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
Immunity · 2020 · https://doi.org/10.1016/j.immuni.2020.11.016
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Cell · 2019 · https://doi.org/10.1016/j.cell.2019.01.041
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
The Lancet Infectious Diseases · 2019 · https://doi.org/10.1016/s1473-3099(19)30312-3
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection · 2018 · https://doi.org/10.1016/j.cmi.2018.01.002
Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus
mSphere · 2017 · https://doi.org/10.1128/msphere.00238-17
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12371
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12465
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi
Clinical Microbiology and Infection · 2014 · https://doi.org/10.1111/1469-0691.12515
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
Clinical Microbiology and Infection · 2013 · https://doi.org/10.1111/1469-0691.12360
ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12040
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12038
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Clinical Microbiology and Infection · 2012 · https://doi.org/10.1111/1469-0691.12039
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa061094
Antimicrobial therapy of unexplained fever in neutropenic patients
Annals of Hematology · 2003 · https://doi.org/10.1007/s00277-003-0764-4
Current projects
No projects listed.